Loading…
Cingulate Inc. is projected to decline to $4.85 by 2027, a -1% move from its current price of $4.91. CING is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $4.68 | $4.90 | $5.14 | -0.13% |
| Jul 15 | $4.58 | $4.90 | $5.24 | -0.26% |
| Jul 16 | $4.50 | $4.89 | $5.31 | -0.40% |
| Jul 17 | $4.44 | $4.88 | $5.37 | -0.53% |
| Jul 18 | $4.39 | $4.88 | $5.42 | -0.66% |
| Jul 19 | $4.34 | $4.87 | $5.47 | -0.79% |
| Jul 20 | $4.29 | $4.86 | $5.52 | -0.92% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.29 | $4.86 | $5.52 | -0.92% |
| Week 2 | $4.03 | $4.82 | $5.76 | -1.83% |
| Week 3 | $3.84 | $4.78 | $5.94 | -2.74% |
| Week 4 | $3.68 | $4.73 | $6.09 | -3.64% |
| Week 5 | $3.54 | $4.69 | $6.21 | -4.52% |
| Week 6 | $3.41 | $4.64 | $6.32 | -5.40% |
| Week 7 | $3.30 | $4.60 | $6.42 | -6.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cingulate Inc. is a biopharmaceutical company that develops pharmaceutical products using its drug delivery platform technology to treat attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. Its lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults.
The company also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD.
Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Cingulate Inc. trades under the symbol CING and operates in the Healthcare sector. The current price is $4.84, reflecting its latest trading level.
The company has a market capitalization of $65.19M and is currently ranked 4438 by market cap. This places it among smaller-cap healthcare players in the market.
The overall price outlook is mixed in the near term, with a neutral near-term setup that shifts to bullish indications over the longer horizon. Forecasts show gradual upside over the coming years, culminating in a 2050 average price of 22.02 with a 354.9 ROI, after a neutral start in 2026 and 2027.
A major floor 48.9% below — a decisive break under it would weaken the trend.
The nearest floor, 26.7% below — buyers have tended to step in here.
The nearest ceiling, 20.0% above — a clean break opens room to run.
A major ceiling 137.5% above — clearing it would confirm fresh momentum.
Key CING support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CING market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.02 | Sell | $5.02 | Sell |
| MA 10 | $5.21 | Sell | $5.07 | Sell |
| MA 20 | $5.06 | Sell | $5.03 | Sell |
| MA 50 | $4.84 | Buy | $5.07 | Sell |
| MA 100 | $5.69 | Sell | $5.21 | Sell |
| MA 200 | $5.04 | Sell | $5.44 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.31 | Neutral |
| Stoch RSI (14) | 6.41 | Buy |
| CCI (20) | -45.87 | Neutral |
| Williams %R (14) | -86.73 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | 1.66 | Buy |
| Bollinger %B (20,2) | 0.37 | Neutral |
| Stochastic %K (14) | 13.27 | Buy |
| TRIX (15) | 0.33 | Buy |
| Awesome (5,34) | 0.21 | Buy |
| Ultimate (7,14,28) | 40.52 | Neutral |
| Momentum (10) | 0.15 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 4.78 | Buy |
| ADX (14) | 9.07 | Neutral |
| ATR (14) | 0.21 | Info |
The short-term technical picture is NEUTRAL, with RSI14 at 50. This suggests a balanced momentum around the current level.
Near-term price action is framed by the moving averages and support/resistance levels: SMA50 is $4.84 and SMA200 is $5.03, indicating the price is hovering around short-term averages. Immediate support is at $3.60 and resistance at $5.89, defining the near-term trading range.
The 30-day range spans from a low of $3.47 to a high of $6.74, illustrating modest upside potential within a defined band over the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.60 | $4.91 | $6.09 | 0% | Neutral | |
| $3.60 | $4.85 | $7.06 | -1% | Neutral | |
| $4.14 | $5.89 | $9.07 | +20% | Neutral | |
| $4.31 | $6.41 | $10.33 | +31% | Bullish | |
| $4.89 | $7.57 | $12.66 | +54% | Bullish | |
| $4.80 | $7.72 | $13.33 | +57% | Bullish | |
| $4.02 | $6.70 | $11.91 | +37% | Bullish | |
| $3.90 | $6.73 | $12.26 | +37% | Bullish | |
| $3.95 | $7.03 | $13.11 | +43% | Bullish | |
| $4.85 | $8.93 | $17.01 | +82% | Bullish | |
| $4.55 | $9.76 | $20.32 | +99% | Bullish | |
| $9.80 | $21.78 | $50.09 | +344% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.60 | $4.91 | $6.03 | +0.00% |
| August 2026 | $3.91 | $4.70 | $5.88 | -4.22% |
| September 2026 | $3.57 | $4.35 | $5.54 | -7.45% |
| October 2026 | $3.63 | $4.48 | $5.79 | +2.87% |
| November 2026 | $3.78 | $4.70 | $6.16 | +5.03% |
| December 2026 | $3.66 | $4.59 | $6.09 | -2.40% |
Click any year to see its month-by-month CING forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cingulate Inc.'s 2026 outlook centres on $4.91, within a $3.60 to $6.09 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, CING could reach as high as $7.06, with a base case around $4.85 and support toward $3.60 — roughly -1% from $4.91. A consolidation phase looks the most probable path here.
Expect CING to range from $4.14 to $9.07 through 2028. The $5.89 average target implies a +20% move from current prices. That is up +21% on the projected 2027 average. Price action looks broadly range-bound.
The CING price prediction for 2029 points to an average of $6.41 (low $4.31, high $10.33) — a potential gain of +31% on today's $4.91. Buyers look set to stay in control over this stretch.
In 2030, CING is projected to trade between $4.89 and $12.66, averaging $7.57 — a potential gain of +54% from today's $4.91. That is up +18% on the projected 2029 average. Momentum favours further upside here.
Cingulate Inc.'s 2031 outlook centres on $7.72, within a $4.80 to $13.33 range. That is up +2% on the projected 2030 average. That marks a +57% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, CING could reach as high as $11.91, with a base case around $6.70 and support toward $4.02 — roughly +37% from $4.91. Momentum favours further upside here.
Expect CING to range from $3.90 to $12.26 through 2033. The $6.73 average target implies a +37% move from current prices. That is up 0% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The CING price prediction for 2034 points to an average of $7.03 (low $3.95, high $13.11) — a potential gain of +43% on today's $4.91. Momentum favours further upside here.
In 2035, CING is projected to trade between $4.85 and $17.01, averaging $8.93 — a potential gain of +82% from today's $4.91. That is up +27% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Cingulate Inc.'s 2040 outlook centres on $9.76, within a $4.55 to $20.32 range. That is up +9% on the projected 2035 average. That marks a +99% change versus current levels. Momentum favours further upside here.
By 2050, CING could reach as high as $50.09, with a base case around $21.78 and support toward $9.80 — roughly +344% from $4.91. Buyers look set to stay in control over this stretch.
Investing $1,000 in CING today (≈ 203.665988 CING) could be worth
$4,435.7
+$3,435.7 (+344%) by 2050 · US Dollar
Based on the average projected CING price of $21.78 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CINGwould be worth at today's price.
$1,000 invested in CING on Jul 10, 2025 (≈ 225.733643 CING) would be worth
$1,108.35
+$108.35 (+10.8%) today · 1.11× · US Dollar
Based on a CING entry price of $4.43 vs. today's $4.91.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.38 | $912.64 | -8.7% |
| 1 month ago | $4.89 | $1,004.09 | +0.4% |
| 3 months ago | $5.76 | $852.43 | -14.8% |
| 6 months ago | $4.87 | $1,008.21 | +0.8% |
| 1 year ago | $4.43 | $1,108.35 | +10.8% |
| All time (4.6y) ago | $1,068 | $4.6 | -99.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CING forecast.
Our base-case forecast reaches $9.80 around 2050.
Implied market cap at $9.80: $132M
The multi-year forecast shows a bullish trajectory developing after 2027. The 2026 forecast lists an avg of 4.84 with a ROI of 0 and a neutral sentiment, followed by 2027 with an avg of 4.80 and a ROI of -0.8, still neutral.
From 2028 onward the outlook becomes more decidedly bullish as average prices rise: 2028 avg 5.89, ROI 21.6, sentiment BULLISH; 2029 avg 6.39, ROI 32.1, sentiment BULLISH; 2030 avg 7.65, ROI 58, sentiment BULLISH. The trend continues with 2031 avg 7.76, ROI 60.3; 2032 avg 6.60, ROI 36.3; 2033 avg 6.72, ROI 38.8; 2034 avg 7.03, ROI 45.2; 2035 avg 8.97, ROI 85.3; 2040 avg 9.68, ROI 100; and 2050 avg 22.02, ROI 354.9, all with bullish sentiment.
These figures imply meaningful upside over the long term, with higher average prices and expanding ROIs by mid-century. However, these are estimates and not guarantees, and there is inherent uncertainty and risk in any forecast.
Tap a question to reveal the answer.
The 2030 forecast shows avg 7.65, min 4.84, max 13.02, ROI 58, sentiment BULLISH.
Forecasts indicate a bullish trajectory from 2028 onward with average prices rising to 22.02 by 2050 and ROI to 354.9, though 2026 shows 0 ROI and 2027 shows -0.8 ROI.
Yes—the max forecast reaches 10.47 in 2029 and 13.02 in 2030.
Current price is $4.84 and market cap is $65.19M.
The 30-day range is from $3.47 to $6.74.
Cingulate Inc. Community Discussion
0Share your Cingulate Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.